• Led and designed market research and competitive intelligence to identify strategies to drive revenue growth by 10% in 5 years by revamping R&D portfolio strategy for immunology and operating model, benefiting a >$10B global biopharmaceutical client.• Developed and strategized $1B cost reduction roadmap across G&A services by 2025 for a global > $20B life science client, by conducting peer competitive and financial modeling, contributing to leaner P&L and evolved business strategies. • Optimized the organization design strategy for a diversified healthcare system to support a growth-focused strategy and achieve ~10% annual EBITDA growth aspiration within 5 years, influenced by expert interviews and balancing centralization.• Empowered, coached, and managed team on validating exploratory analysis of >$2B of medical supplier pipeline for national integrated delivery network resulting in refined savings roadmap of $300M within 3 years.• Led and supervised cross-functional teams in implementing and executing 50+ initiatives for service suppliers and pharmacy transformations using refined KPIs and governance, yielding increased savings by 15-20% within 2 years for AMC.• Overhauled value capture category strategies in 20+ opportunities in supply chain, resulting in over $100M in savings on a $1B base spend for a national health system by 2025, contributing to cost reduction and improved operational performance.• Elevated revenue growth management strategies for global F100 chemicals company, unlocking 4-7% return on sales within 3 years by identifying commercial analytical opportunities from stakeholder insights.• Facilitated and organized process mapping workshop to uncover $250M profit potential in AI / Gen AI strategies within 2 years for $1B+ oilfield services company, identifying potential operational enhancements and financial gains.

Ben and Kay Mayberry ScholarProspanica ScholarJones Board FellowCommunication FellowRice Admission Ambassador

Crafted market-informed guidance to yield actionable aerospace insights for firm and revenue growth

Performed marketing analysis to identify trends and benchmark strategies in pharmaceutical industry; organized and presented findings to relevant stakeholders

• Established and championed strategic vision and integration for 25 nano- and cell therapy-based projects involving 12 partners across oncology, immunology, and cardiovascular, contributing to 20 articles and advancing institutional/center milestones.• Supervised and streamlined cross-functional teams, managing deliverables and analytics for projects, publications, budgets, and report submissions; coordinated implementation of engagement tools to increase productivity by 50% in 12 months.

• Managed and coordinated 5 multi-national teams to extract, analyze, and create novel innovations in nano-based drug and gene delivery and played role to foster cross-functional synergies and communication for large projects, resulting in 25 articles.• Restructured HMH Trainee Association, elevating attendance by 50% through the implementation of new organizational frameworks, fostering accountability and role clarity with completed roll-out in 3 months.• Coordinated 2nd largest career symposium in U.S.; directed team of 23 to achieve 33% increase in attendance, while decreasing expenses by 20% by implementing cost-reduction strategies to $30K budget.

o Performed due diligence and competitive analysis for commercialization of early-stage companies in radiopharmaceuticals ($10B) and anemia management ($12B) markets, leading to improved market positioning and investor confidence.o Developed strategic plan to allocate $40K for future investments, demonstrating financial acumen and contributing to long-term business sustainability.